Macro Featured

The Pay Cut Hiding in Your Benefits Letter

Employer health costs are projected to rise 9.5% in 2027 — a fourth straight year near double digits, pushing coverage above $19,000 per employee. This fall is when companies stop absorbing it, and the increase lands in 150 million paychecks.

Alpha One

31 Aug 2026 • 7 min read

Sometime in the next ten weeks, roughly 150 million Americans with job-based health insurance will get a letter, an email, or a portal notification from HR. It will be written in the gentle dialect of benefits departments — "plan enhancements," "updated contribution structures," "new wellness options." Buried in the tables will be the actual message: your health insurance is about to cost more. Probably a lot more. And this year, for the first time in this cycle, your employer is less likely to eat the difference for you.

Two numbers published in the last two weeks explain why this fall's open enrollment is different. On August 20, Aon projected that US employer health care costs will rise 9.5% in 2027 — pushing the average cost of covering a single employee above $19,000 a year. Five days later, the Business Group on Health released its survey of large employers: they expect a median cost trend of 9.2% for 2027, before plan changes shave it to roughly 8%.

Those are not shock numbers on their own. What makes them matter is the streak they extend. This is now the fourth consecutive year of employer health cost growth at or near double digits — what Aon calls one of the most sustained runs of health care inflation employers have faced in decades. By Aon's data, the employer's annual cost increase has more than doubled since 2022, from 3.7% to 8.8% this year. Health inflation stopped being a bad year some time ago. It has become the operating environment.

Where the money is going

The total cost of an average employer health plan hit $17,562 per employee in 2026, up 8.3% in a single year. And the average understates how ugly the distribution is: the middle half of employers saw increases ranging from 5.5% to 11.5%. If your company is on the wrong end of that range, its health plan is inflating at more than three times the rate of general consumer prices.

The drivers are structural, which is why four years of "temporary" spikes keep failing to mean-revert:

Pharmacy is the engine. Prescription drugs are now roughly a quarter of employer health spend and compounding at about 12% a year, per the Business Group on Health survey. GLP-1 drugs — Ozempic, Wegovy, Zepbound and their successors — started as a weight-loss line item and are now expanding into cardiovascular disease, sleep apnea, and chronic kidney disease, with cheaper oral versions widening the funnel of eligible patients faster than prices fall.

Utilization keeps climbing. More care is being consumed per person — more chronic conditions under management, more high-cost claims, more specialty treatments that did not exist five years ago.

And a genuinely new one: AI-assisted billing. Aon flagged that providers are adopting technologies, including AI, that produce more detailed clinical documentation and coding — which translates, in some cases, into higher billed charges. The software arms race between hospitals that bill and insurers that deny has found its way into your premium. Both sides now have machines; the invoice is the battlefield.

Briefings like this land in members' inboxes before the market prices them in. Join free →

The absorption era is ending

Here is the part of this story that has been genuinely under-appreciated: for four years, workers have been substantially shielded from these numbers. Employers absorbed the hits. Aon's data shows companies still cover about 82% of total plan costs, and in 2026 they let their own share of costs rise 8.8% while holding employee paycheck contributions to a 6.4% increase. In a labor market where talent was scarce, eating the health care increase was a retention strategy.

That shield is now visibly cracking, in three places.

First, out-of-pocket costs are already leaking through. Employee out-of-pocket spending jumped 10.2% in 2026 — faster than premiums, faster than wages — as workers got steered into leaner plans with higher deductibles. Total employee health costs (payroll contributions plus out-of-pocket) hit $5,297 this year, approaching $5,300 per insured worker before a single 2027 increase lands.

Second, benefits are quietly shrinking. About 14% of US employers have dropped or plan to drop GLP-1 coverage for weight loss in 2027, per the Business Group on Health survey — the first large-scale retreat from what was, two years ago, the most demanded benefit in corporate America. Others are adding surcharges, tightening eligibility, and carving out categories of care.

Third — and this is the one that shows up in the macro data — employers are telling surveyors, explicitly, that cost volatility is forcing a strategic overhaul. When the consultants who set renewal pricing project 9.5% and the employers who pay it project 9.2%, the negotiation that follows is not about whether workers pay more in 2027. It is about how much more, and through which door: premium share, deductible, or dropped coverage.

A wage story wearing a health care costume

Why does this belong in an intelligence briefing about markets rather than an HR newsletter? Because $19,000 per employee is not a benefits statistic. It is compensation — roughly a third of the median full-time US salary, paid in a currency workers never see.

Companies plan total compensation budgets, not salary budgets. Every point of health care inflation above wage growth is a transfer from the raise pool to the premium pool. When the health line grows 9% and the total comp budget grows 4%, the difference comes out of cash wages — invisibly, structurally, and regardless of what the labor market is doing. Economists have documented this crowd-out for decades; what is unusual now is the scale: four consecutive years of near-double-digit health trend colliding with a cooling labor market that has stripped workers of the leverage to demand offsetting raises.

That collision has three consequences worth watching from a market seat:

It is a stealth squeeze on the consumer that does not show up cleanly in wage data. A worker whose salary rises 3.5% while payroll premium contributions rise 6.4% and out-of-pocket costs rise 10.2% is experiencing a real income decline in their health-adjusted paycheck — one reason consumer sentiment, at 51.7 in the University of Michigan's August reading, keeps printing levels normally associated with recessions while headline wage growth looks respectable.

It is inflation the Federal Reserve cannot reach. Health care services inflation responds to demographics, drug pipelines, provider consolidation, and billing technology — not to the federal funds rate. With the Fed already tilted hawkish, a durable 9% health trend hardens the services floor under core inflation and does its damage regardless of what happens to rates. Tight policy can crush housing and goods; it cannot make a GLP-1 cheaper or un-train a hospital coding model.

It lands hardest on exactly the sectors that hire the most. Aon's industry breakdown shows finance and insurance employers absorbing 9.8% cost increases and technology firms 9.1% — but the pain concentrates in low-margin, labor-heavy businesses (retail, restaurants, logistics) where a $19,000-per-head fixed cost is a hiring decision, not a rounding error. At the margin, this is a tax on employment itself, arriving in the same quarter the labor market is already decelerating.

What to watch

The next data points arrive on a known calendar. KFF's annual employer benefits survey — the benchmark that will confirm or contest these projections — lands in the fall. Open enrollment season runs October into November; the aggregate shape of 2027 cost-shifting will be visible in anecdotes by Halloween and in the data by spring. Third-quarter earnings calls will carry benefits-cost commentary from the big employers of record — Walmart, Amazon, UPS — and margin guidance from the insurers writing the renewals. And in Washington, the pharmacy-benefit-manager reform effort that has been circling Congress for three years now has a 9.5% headline to legislate against.

The letter that lands in American inboxes this fall will be polite, formatted, and full of wellness language. The message underneath it is the one this page has tried to translate: the four-year truce in which employers quietly absorbed America's health care inflation is ending, and the pass-through — to paychecks, to consumption, to inflation's stubborn services floor — is just beginning.

Get this level of intelligence every day. Subscribe to AlphaBriefing — free, member, and paid tiers available.

If this analysis was useful, this is what AlphaBriefing does every day — geopolitics and markets, connected to what it means for your money. Free members get the daily brief in their inbox; paid members get the investment frameworks, scenario pricing, and catalyst calendars behind the paywall.

Sign up free → — upgrade whenever it earns it.

Sources & Further Reading

Disclaimer

AlphaBriefing is an independent intelligence publication. The content in this article is produced for informational and educational purposes only. Nothing published by AlphaBriefing constitutes financial, investment, legal, tax, or regulatory advice, nor should it be construed as a solicitation or recommendation to buy, sell, or hold any security, asset, or financial instrument.

All views expressed are those of the author at the time of writing and are subject to change without notice. Markets are volatile and unpredictable; past performance is not indicative of future results. Any investment involves risk, including the possible loss of principal.

AlphaBriefing and its principals, employees, or contributors may hold positions in securities or assets mentioned in this article. This should be considered a potential conflict of interest. No material relationship with any company referenced exists unless explicitly disclosed. Readers should conduct their own due diligence and consult qualified financial, legal, and tax advisors before making any investment decisions.

Information in this article is drawn from public sources believed to be reliable at the time of publication. AlphaBriefing makes no warranty, express or implied, as to the accuracy, completeness, or timeliness of any information herein. AlphaBriefing accepts no liability for any loss or damage arising from reliance on this content.